Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings Estimates

Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 100%. A quarter ago, it was expected that this pharmaceutical company would post earnings of $0.12 per share when it actually produced earnings of $0.19, delivering a surprise of 58.33%.Over the last four qu ...